Will widespread use of artificial intelligence tools in manuscript writing mark the end of human scholarship as we know it? escienceediting.org/journal/view.p…

Draft of The New #BSR25 Lupus Nephritis Guidelines #Rheumatology #MedTwitter [Yuz Yusof]

FDA has approved upadacitinib (Rinvoq) for treatment of adults with Giant Cell Arteritis (GCA). This is the 9th indication for the drug. investingnews.com/rinvoq-r-recei…

Physical examination tests for neurological deficits related to lumbar disc herniation, outlining the expected pain distribution, numbness, weakness, atrophy, and reflex changes associated with different levels of herniation. (Frank Netter)

✅ Do you have #LUPUS and #BRAINFOG? If so, we would like to INVITE YOU to contribute to our research STUDY for the development of the Lupus Brain Fog Severity Scale - a questionnaire to assess the characteristics and severity of brainfog in lupus 🦋 LINK:lupusresearch.limequery.org/697679?lang=en

🧠 Brainfog is one of the most invisible symptoms of lupus, and it still has no official scale. Prof. Laurent ARNAUD & LBFSS team, with the support of Lupus Europe, are changing that—and they need YOU. 📲 Fill the survey. Let’s make brainfog visible. 🔗 lupusresearch.limequery.org/697679?lang=en

Eosinophilic fasciitis (Shulman disease) needs IV pulse steroids. Poor prognosis relates to delayed diagnosis and lack of high dose steroids (as opposed to SSc where you want to avoid high dose steroids) #CCRE25 Dr K Shaw

Anti-synthetase syndrome (ASyS): Consensus on nomenclature and abbreviation for anti-synthetase syndrome is now done. Everyone should use this nomenclature and abbreviation for the ASyS going forward: an IMACS project academic.oup.com/rheumatology/a…

Full read review of Neuropsychiatric SLE. NPSLE criteria includes 12 central & 7 peripheral findings (psych, cognitive, Sz, CVA/TIA, neuropathy, MS-like). NPSLE AutoAbs are many: Abs against APL, LAC, RP, NMDA, NMO/AQP4, EC, SBSN, UCH-L1, TP1, GAPDH, MAP2, U1RNP

This is soo similar to our international consensus on rare #lupus manifestations (only that we didn't make recommendations based on no evidence 😏) For me it will be very interesting to see who is an author on this ACR 'extract' and who was ALSO involved in our work - Ethics 🏆🏅

Editors pick for #EULAR2025—ERN ReCONNET 🇪🇺–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic #lupus erythematosus manifestations bit.ly/3YXEmAO Free to read with registration on lancet.com (also free) Laurent ARNAUD #SLE

✅ Thank you EULAR for the opportunity of this plenary session on relapsing #polychondritis ⬇️ at #EULAR2025. Thanks to all of you who have attended this early Saturday session 👍

🚨 #Recommendations #lupus #nephritis 👀⬇️ #EULAR2025

It’s an honor to promote free education in Musculoskeletal Ultrasound (#MSUS) and Rheumatology. We are happy to share the MSUS Database: over 1,000 images and videos of sonoanatomy and pathology, accessible with a single click from anywhere in the world 🌍 🌎 , even where

✅ Very happy to report that we have completed STEP 2 of #LUPUSALERT, asking a large international panel to triage & prioritize #lupus #vulnerabilities suggested during step 1, for inclusion in the final screening questionnaire 👍 Thanks to you all for your contributions 👏

✅ Thank you Lupus Canada for your post about our work #SLAKE ⬇️

✅ Very happy to report that we have completed the entiere STEP1 of #ENDORSED, the international #consensus definition of #SEVERE #LUPUS by the #DORIS group gathering 50+ potential facets of severity thanks to the international panel of HCPs (step 1a) and patients (step 1b) 👍

New #Nature Reviews Disease Primer on #lupusnephritis. rdcu.be/eH6A4 Happy to have contributed! Work done together with respected colleagues Mohan Lab Brad H Rovin Hans-Joachim Anders Maria Tektonidou Ana Malvar and CC Mok Parodis lab #lupus

🆕 ILD (Part III): clinical practice focus 🔬 Diagnostic challenges 🧑⚕️ Case-based learning 📈 Evidence & outcomes 🌍 Global perspectives ⬇️ Download & learn more: buff.ly/hQtsW1A Created by Mithu Maheswaranathan, MD | For our Rheum to Breathe: ILD Campaign

Part of the special collection #Sjögren’s Syndrome: 👉rdcu.be/eLJnm 🧬Precision T2T strategies are emerging in Sjögren’s-linking clinical & molecular endotypes to tailored therapies 🔹B cell & IFN-driven subtypes 🔹Dynamic biomarker monitoring 🔹AI-assisted precision